2025 Non-CME/CE Bonus Presentations
Friday, January 17, 2025 | 12:15 PM – 1:30 PM
Room: Mediterranean 8
Program Summary: During this presentation, Dr Bhatia will discuss clinical trial data for a treatment option for moderate-to-severe atopic dermatitis. He will illustrate how he educates appropriate patients about this oral JAK inhibitor and what treatment may mean for patients.
Saturday, January 18, 2025 | 9:15 AM – 10:15 AM
Room: Mediterranean 6
Program Summary: Please join Dr. Adam Friedman and Dr. Tim Flynn for a presentation on managing symptoms of xerosis and atopic dermatitis in ethnically diverse patients with prebiotic skincare. New research on clinical manifestations & symptoms, plus quality-of-life will be discussed.
Room: Mediterranean 8
Program Summary: Join us for a special ODAC Session: Make SILIQ® (brodalumab) injection, 210 mg/ 1.5 mL Your BIO-Logical Next Step.
Saturday, January 18, 2025 | 12:45 PM – 1:45 PM
Room: Mediterranean 6
Program Summary: A review of data from the latest study in patients with low BSA, moderate plaque psoriasis and special site involvement.
Room: Mediterranean 8
Saturday, January 18, 2025 | 3:45 PM – 4:45 PM
Room: Mediterranean 6
Room: Mediterranean 8
Program Summary: This session will explore mechanisms and practical insights for integrating pre-aging and hydration innovations into patient care strategies.
Sunday, January 19, 2025 | 9:15 AM – 10:15 AM
Room: Mediterranean 6
Room: Mediterranean 8
Sunday, January 19, 2025 | 12:30 PM – 1:30 PM
Room: Mediterranean 6
Program Summary: Come learn more about how type 2 inflammation contributes to the clinical manifestations of type 2 inflammatory diseases and which cytokines play key roles in driving this activity.
Room: Mediterranean 8
Program Summary: Join renowned dermatologists Dr. Vishal Patel and Dr. Meenal Kheterpal for an engaging 30-minute educational session focused on the latest advancements in the treatment of locally advanced basal cell carcinoma (laBCC) using ODOMZO (sonidegib). This dynamic discussion will delve into the clinical efficacy, safety profile, and practical applications of ODOMZO in managing laBCC. Following the conversation, there will be a 15-minute Q&A session, providing participants with the opportunity to interact directly with the experts, ask questions, and discuss challenges and solutions in treating laBCC.
Sunday, January 19, 2025 | 3:45 PM – 5:30 PM
RESIDENTS ONLY :
Room: Mediterranean 7